Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852462 · ClinicalTrials.gov registry record · Phase 2
Lung Cancer Symptom Assessment and Management Intervention
A Phase 2 study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 179
- Enrollment target
NCT00852462 is a Phase 2 study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 179 participants.
The verdict
NCT00852462, a Phase 2 study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 179 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).
Interventions
- BEHAVIORAL SAMI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2008-05 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852462
The ClinicalTrials.gov registry entry for NCT00852462 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SAMI is the first listed.
NCT00852462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00852462 about?
NCT00852462 is a clinical study titled "Lung Cancer Symptom Assessment and Management Intervention". The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).
What is the current status of trial NCT00852462?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 179 participants. The study started on 2008-05. Estimated completion is 2016-06.
What interventions are being tested in trial NCT00852462?
The interventions under investigation include: SAMI (BEHAVIORAL).
Who is sponsoring clinical trial NCT00852462?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.